How effective are antioxidant supplements in obesity and diabetes?

Medical Principles and Practice

Volumn 24, Issue 3, 2015, Pages 201-215

  Abdali, Daniyal ^a   Samson, Sue E ^a   Grover, Ashok Kumar ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Carnitine; Cinnamon; Green coffee; Green tea; Lipoic acid; Vitamin C

Indexed keywords

ADIPONECTIN; ALBUMIN; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; C REACTIVE PROTEIN; CARNITINE; CYTOKINE; GLUCOSE; GLUCOSE TRANSPORTER 4; GLUTATHIONE PEROXIDASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 2; INTERLEUKIN 6; LEPTIN; LYCOPENE; MALONALDEHYDE; OMEGA 3 FATTY ACID; OXIDIZED LOW DENSITY LIPOPROTEIN; POLYPHENOL; REACTIVE OXYGEN METABOLITE; RESVERATROL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOCTIC ACID; TUMOR NECROSIS FACTOR ALPHA; UBIDECARENONE; UBIQUINONE; ZINC; BIOLOGICAL MARKER; FATTY ACID; FTO PROTEIN, HUMAN; MC4R PROTEIN, HUMAN; MELANOCORTIN 4 RECEPTOR; PCSK1 PROTEIN, HUMAN; PROPROTEIN CONVERTASE 1; PROTEIN; VITAMIN;

ARTICLE; CINNAMON; COMPUTER ASSISTED TOMOGRAPHY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; ETHNICITY; HORMONAL REGULATION; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INNATE IMMUNITY; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; TEA; WHITE ADIPOSE TISSUE; ADIPOSE TISSUE; BODY MASS; COMPLICATION; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION; GENETICS; METABOLISM; OVERWEIGHT; PHYSIOLOGY;

ADIPOSE TISSUE; ANTIOXIDANTS; BIOMARKERS; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FATTY ACIDS, NONESTERIFIED; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; LEPTIN; OBESITY; OVERWEIGHT; OXIDATIVE STRESS; PROPROTEIN CONVERTASE 1; PROTEINS; REACTIVE OXYGEN SPECIES; RECEPTOR, MELANOCORTIN, TYPE 4; VITAMINS;

EID: 84929966272     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000375305     Document Type: Article

References (98)

1. Behbehani K: Kuwait National Programme for Healthy Living: first 5-year plan (2013-2017). Med Princ Pract 2014; 23(suppl 1):32-42.
2. Hotamisligil GS: Inflammation and metabolic disorders. Nature 2006; 444: 860-867.
3. World Health Organization. Obesity: preventing and managing the global epidemic. http://www.who.int/nutrition/publications/obesity/WHO-TRS-894/en/. 2000.
4. Bruckert E: Abdominal obesity: a health threat (in French). Presse Med 2008; 37: 1407-1414.
5. Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-887.
6. Schelbert KB: Comorbidities of obesity. Prim Care 2009; 36: 271-285.
7. Al Lawati JA, Barakat NM, Al Lawati AM, et al: Optimal cut-points for body mass index, waist circumference and waist-to-hip ratio using the Framingham coronary heart disease risk score in an Arab population of the Middle East. Diab Vasc Dis Res 2008; 5: 304-309.
8. Brennan DD, Whelan PF, Robinson K, et al: Rapid automated measurement of body fat distribution from whole-body MRI. AJR Am J Roentgenol 2005; 185: 418-423.
9. Hofker M, Wijmenga C: A supersized list of obesity genes. Nat Genet 2009; 41: 139-140.
10. Wood IS, Trayhurn P: Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr 2003; 89: 3-9.
11. Foley K, Boguslavsky S, Klip A: Endocytosis, recycling, and regulated exocytosis of glucose transporter 4. Biochemistry 2011; 50: 3048-3061.
12. Fantuzzi G: Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 911-919.
13. Wisse BE: The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004; 15: 2792-2800.
14. Walia M, Kwan CY, Grover AK: Effects of free radicals on coronary artery. Med Princ Pract 2003; 12: 1-9.
15. Fridovich I: Oxygen: how do we stand it? Med Princ Pract 2013; 22: 131-137.
16. Giacco F, Brownlee M: Oxidative stress and diabetic complications. Circ Res 2010; 107: 1058-1070.
17. Rudich A, Kanety H, Bashan N: Adipose stress-sensing kinases: linking obesity to malfunction. Trends Endocrinol Metab 2007; 18: 291-299.
18. Jones DP: Redefining oxidative stress. Antioxid Redox Signal 2006; 8: 1865-1879.
19. Forman HJ, Davies KJ, Ursini F: How do nutritional antioxidants really work: nucleophilic tone and para-hormesis versus free radical scavenging in vivo. Free Radic Biol Med 2014; 66: 24-35.
20. Liochev SI: Free radicals: how do we stand them? Anaerobic and aerobic free radical (chain) reactions involved in the use of fluorogenic probes and in biological systems. Med Princ Pract 2014; 23: 195-203.
21. Vincent HK, Innes KE, Vincent KR: Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes Obes Metab 2007; 9: 813-839.
22. Kitabchi AE, McDaniel KA, Wan JY, et al: Effects of high-protein versus high-carbohydrate diets on markers of beta-cell function, oxidative stress, lipid peroxidation, proinflammatory cytokines, and adipokines in obese, premenopausal women without diabetes: a randomized controlled trial. Diabetes Care 2013; 36: 1919-1925.
23. Esteghamati A, Eskandari D, Mirmiranpour H, et al: Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: a randomized clinical trial. Clin Nutr 2013; 32: 179-185.
24. Golbidi S, Badran M, Laher I: Diabetes and alpha lipoic acid. Front Pharmacol 2011; 2: 69.
25. Niki E: Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence. Free Radic Biol Med 2014; 66: 3-12.
26. Harding AH, Wareham NJ, Bingham SA, et al: Plasma vitamin C level, fruit and vegetable consumption, and the risk of new-onset type 2 diabetes mellitus: the European prospective investigation of cancer-Norfolk prospective study. Arch Intern Med 2008; 168: 1493-1499.
27. Rafighi Z, Shiva A, Arab S, Mohd YR: Association of dietary vitamin C and E intake and antioxidant enzymes in type 2 diabetes mellitus patients. Glob J Health Sci 2013; 5: 183-187.
28. Naziroglu M, Simsek M, Simsek H, et al: The effects of hormone replacement therapy combined with vitamins C and E on antioxidants levels and lipid profiles in postmenopausal women with type 2 diabetes. Clin Chim Acta 2004; 344: 63-71.
29. Kataja-Tuomola MK, Kontto JP, Mannisto S, et al: Intake of antioxidants and risk of type 2 diabetes in a cohort of male smokers. Eur J Clin Nutr 2011; 65: 590-597.
30. Ristow M, Zarse K, Oberbach A, et al: Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci USA 2009; 106: 8665-8670.
31. Rotilio G, Calabrese L, Bossa F, et al: Properties of the apoprotein and role of copper and zinc in protein conformation and enzyme activity of bovine superoxide dismutase. Biochemistry 1972; 11: 2182-2187.
32. Vashum KP, McEvoy M, Shi Z, et al: Is dietary zinc protective for type 2 diabetes? Results from the Australian longitudinal study on women's health. BMC Endocr Disord 2013; 13: 40.
33. Hussain SA, Khadim HM, Khalaf BH, et al: Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin. Saudi Med J 2006; 27: 1483-1488.
34. Gunasekara P, Hettiarachchi M, Liyanage C, et al: Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetes. Diabetes Metab Syndr Obes 2011; 4: 53-60.
35. Roussel AM, Kerkeni A, Zouari N, et al: Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J Am Coll Nutr 2003; 22: 316-321.
36. Partida-Hernandez G, Arreola F, Fenton B, et al: Effect of zinc replacement on lipids and lipoproteins in type 2 diabetic patients. Biomed Pharmacother 2006; 60: 161-168.
37. Seet RC, Lee CY, Lim EC, et al: Oral zinc supplementation does not improve oxidative stress or vascular function in patients with type 2 diabetes with normal zinc levels. Atherosclerosis 2011; 219: 231-239.
38. Parham M, Amini M, Aminorroaya A, et al: Effect of zinc supplementation on microalbuminuria in patients with type 2 diabetes: a double-blind, randomized, placebo-controlled, cross-over trial. Rev Diabet Stud 2008; 5: 102-109.
39. Jayawardena R, Ranasinghe P, Galappatthy P, et al: Effects of zinc supplementation on diabetes mellitus: a systematic review and metaanalysis. Diabetol Metab Syndr 2012; 4: 13.
40. Radke GA, Ono K, Ravindran S, et al: Critical role of a lipoyl cofactor of the dihydrolipoyl acetyltransferase in the binding and enhanced function of the pyruvate dehydrogenase kinase. Biochem Biophys Res Commun 1993; 190: 982-991.
41. Wagenknecht T, Frank J: Localization of lipoyl-bearing domains in the alpha-ketoglutarate dehydrogenase multienzyme complex. Biochemistry 1984; 23: 3383-3389.
42. Biewenga GP, Haenen GR, Bast A: The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 1997; 29: 315-331.
43. Carbonelli MG, Di Renzo L, Bigioni M, et al: ?-Lipoic acid supplementation: a tool for obesity therapy? Curr Pharm Des 2010; 16: 840-846.
44. Ansar H, Mazloom Z, Kazemi F, et al: Effect of ?-lipoic acid on blood glucose, insulin resistance and glutathione peroxidase of type 2 diabetic patients. Saudi Med J 2011; 32: 584-588.
45. Kamenova P: Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of ?-lipoic acid. Hormones (Athens) 2006; 5: 251-258.
46. McNeilly AM, Davison GW, Murphy MH, et al: Effect of ?-lipoic acid and exercise training on cardiovascular disease risk in obesity with impaired glucose tolerance. Lipids Health Dis 2011; 10: 217.
47. Koh EH, Lee WJ, Lee SA, et al: Effects of ?-lipoic acid on body weight in obese subjects. Am J Med 2011; 124: 85-88.
48. Zhang Y, Han P, Wu N, et al: Amelioration of lipid abnormalities by ?-lipoic acid through antioxidative and anti-inflammatory effects. Obesity (Silver Spring) 2011; 19: 1647-1653.
49. Gianturco V, Bellomo A, D'Ottavio E, et al: Impact of therapy with ?-lipoic acid (ALA) on the oxidative stress in the controlled NIDDM: a possible preventive way against the organ dysfunction? Arch Gerontol Geriatr 2009; 49(suppl 1):129-133.
50. Xiao C, Giacca A, Lewis GF: Short-term oral ?-lipoic acid does not prevent lipid induced dysregulation of glucose homeostasis in obese and overweight nondiabetic men. Am J Physiol Endocrinol Metab 2011; 301:E736-E741.
51. Normann PT, Flatmark T: Long-chain acyl-CoA synthetase and 'outer' carnitine longchain acyltransferase activities of intact brown adipose tissue mitochondria. Biochim Biophys Acta 1978; 530: 461-473.
52. Derosa G, Maffioli P, Ferrari I, et al: Comparison between orlistat plus L-carnitine and orlistat alone on inflammation parameters in obese diabetic patients. Fundam Clin Pharmacol 2011; 25: 642-651.
53. Derosa G, Maffioli P, Salvadeo SA, et al: Sibutramine and L-carnitine compared to sibutramine alone on insulin resistance in diabetic patients. Intern Med 2010; 49: 1717-1725.
54. Malaguarnera M, Vacante M, Motta M, et al: Effect of L-carnitine on the size of low-density lipoprotein particles in type 2 diabetes mellitus patients treated with simvastatin. Metabolism 2009; 58: 1618-1623.
55. Galvano F, Li VG, Malaguarnera M, et al: Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in type 2 diabetes mellitus. Expert Opin Pharmacother 2009; 10: 1875-1882.
56. Vidal-Casariego A, Burgos-Pelaez R, Martinez-Faedo C, et al: Metabolic effects of L-carnitine on type 2 diabetes mellitus: systematic review and meta-analysis. Exp Clin Endocrinol Diabetes 2013; 121: 234-238.
57. Lands B: Historical perspectives on the impact of n-3 and n-6 nutrients on health. Prog Lipid Res 2014; 55: 17-29.
58. Munro IA, Garg ML: Dietary supplementation with long chain omega-3 polyunsaturated fatty acids and weight loss in obese adults. Obes Res Clin Pract 2013; 7:e173-e181.
59. Munro IA, Garg ML: Dietary supplementation with n-3 PUFA does not promote weight loss when combined with a very-low-energy diet. Br J Nutr 2012; 108: 1466-1474.
60. Summers LK, Fielding BA, Bradshaw HA, et al: Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia 2002; 45: 369-377.
61. Crane FL: Biochemical functions of coenzyme Q10. J Am Coll Nutr 2001; 20: 591-598.
62. Lee YJ, Cho WJ, Kim JK, et al: Effects of coenzyme Q10 on arterial stiffness, metabolic parameters, and fatigue in obese subjects: a double-blind randomized controlled study. J Med Food 2011; 14: 386-390.
63. Kolahdouz MR, Hosseinzadeh-Attar MJ, Eshraghian MR, et al: The effect of coenzyme Q10 supplementation on metabolic status of type 2 diabetic patients. Minerva Gastroenterol Dietol 2013; 59: 231-236.
64. Hamilton SJ, Chew GT, Watts GF: Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients. Diabetes Care 2009; 32: 810-812.
65. Sohet FM, Delzenne NM: Is there a place for coenzyme Q in the management of metabolic disorders associated with obesity? Nutr Rev 2012; 70: 631-641.
66. Gu L, Kelm MA, Hammerstone JF, et al: Liquid chromatographic/electrospray ionization mass spectrometric studies of proanthocyanidins in foods. J Mass Spectrom 2003; 38: 1272-1280.
67. Khan A, Safdar M, Ali Khan MM, et al: Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 2003; 26: 3215-3218.
68. Mang B, Wolters M, Schmitt B, et al: Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2. Eur J Clin Invest 2006; 36: 340-344.
69. Lu T, Sheng H, Wu J, et al: Cinnamon extract improves fasting blood glucose and glycosylated hemoglobin level in Chinese patients with type 2 diabetes. Nutr Res 2012; 32: 408-412.
70. Roussel AM, Hininger I, Benaraba R, et al: Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese. J Am Coll Nutr 2009; 28: 16-21.
71. Crawford P: Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial. J Am Board Fam Med 2009; 22: 507-512.
72. Vanschoonbeek K, Thomassen BJ, Senden JM, et al: Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients. J Nutr 2006; 136: 977-980.
73. Blevins SM, Leyva MJ, Brown J, et al: Effect of cinnamon on glucose and lipid levels in noninsulin-dependent type 2 diabetes. Diabetes Care 2007; 30: 2236-2237.
74. Woehrlin F, Fry H, Abraham K, et al: Quantification of flavoring constituents in cinnamon: high variation of coumarin in cassia bark from the German retail market and in authentic samples from Indonesia. J Agric Food Chem 2010; 58: 10568-10575.
75. Ranasinghe P, Jayawardana R, Galappaththy P, et al: Efficacy and safety of 'true' cinnamon ( Cinnamomum zeylanicum ) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis. Diabet Med 2012; 29: 1480-1492.
76. All about green tea: major components and health benefits of green tea. http://www.itoen. co.jp/eng/allabout-greentea/components-benefit.html. ITO EN, 2014.
77. Auvichayapat P, Prapochanung M, Tunkamnerdthai O, et al: Effectiveness of green tea on weight reduction in obese Thais: a randomized, controlled trial. Physiol Behav 2008; 93: 486-491.
78. Chantre P, Lairon D: Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Phytomedicine 2002; 9: 3-8.
79. Hsu CH, Liao YL, Lin SC, et al: Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Altern Med Rev 2011; 16: 157-163.
80. Westerterp-Plantenga MS, Lejeune MP, Kovacs EM: Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Obes Res 2005; 13: 1195-1204.
81. Ammon HP: Biochemical mechanism of caffeine tolerance. Arch Pharm (Weinheim) 1991; 324: 261-267.
82. Kang C, Lee H, Jung ES, et al: Saffron ( Crocus sativus L.) increases glucose uptake and insulin sensitivity in muscle cells via multipathway mechanisms. Food Chem 2012; 135: 2350-2358.
83. Vinson JA, Burnham BR, Nagendran MV: Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects. Diabetes Metab Syndr Obes 2012; 5: 21-27.
84. Onakpoya I, Terry R, Ernst E: The use of green coffee extract as a weight loss supplement: a systematic review and meta-analysis of randomised clinical trials. Gastroenterol Res Pract 2011; 2011: 382852.
85. Mancuso C, Santangelo R: Ferulic acid: pharmacological and toxicological aspects. Food Chem Toxicol 2014; 65: 185-195.
86. Karasawa K, Uzuhashi Y, Hirota M, et al: A matured fruit extract of date palm tree ( Phoenix dactylifera L.) stimulates the cellular immune system in mice. J Agric Food Chem 2011; 59: 11287-11293.
87. Timmers S, Hesselink MK, Schrauwen P: Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits? Ann NY Acad Sci 2013; 1290: 83-89.
88. Brasnyo P, Molnar GA, Mohas M, et al: Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr 2011; 106: 383-389.
89. Bhatt JK, Thomas S, Nanjan MJ: Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr Res 2012; 32: 537-541.
90. Crandall JP, Oram V, Trandafirescu G, et al: Pilot study of resveratrol in older adults with impaired glucose tolerance. J Gerontol A Biol Sci Med Sci 2012; 67: 1307-1312.
91. Poulsen MM, Vestergaard PF, Clasen BF, et al: High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes 2013; 62: 1186-1195.
92. Yoshino J, Conte C, Fontana L, et al: Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metab 2012; 16: 658-664.
93. Friedman M: Anticarcinogenic, cardioprotective, and other health benefits of tomato compounds lycopene, ?-tomatine, and tomatidine in pure form and in fresh and processed tomatoes. J Agric Food Chem 2013; 61: 9534-9550.
94. Coyne T, Ibiebele TI, Baade PD, et al: Diabetes mellitus and serum carotenoids: findings of a population-based study in Queensland, Australia. Am J Clin Nutr 2005; 82: 685-693.
95. Ghavipour M, Saedisomeolia A, Djalali M, et al: Tomato juice consumption reduces systemic inflammation in overweight and obese females. Br J Nutr 2013; 109: 2031-2035.
96. Upritchard JE, Sutherland WH, Mann JI: Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care 2000; 23: 733-738.
97. Health Canada, Canadian Nutrient File. http://webprod3.hc-sc.gc.ca/cnf-fce/newNutrientSearch-nouvelleRechercheAliment. do?lang = eng/. 2012.
98. Linus Pauling Institute at Oregon State University, Micronutrient Information Center. http://lpi.oregonstate.edu/infocenter/contentnuts. html/. 2014.